These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 33373779)

  • 21. A comparison of two methods for estimating DCE-MRI parameters via individual and cohort based AIFs in prostate cancer: a step towards practical implementation.
    Fedorov A; Fluckiger J; Ayers GD; Li X; Gupta SN; Tempany C; Mulkern R; Yankeelov TE; Fennessy FM
    Magn Reson Imaging; 2014 May; 32(4):321-9. PubMed ID: 24560287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of liver fibrosis using pharmacokinetic parameters of dynamic contrast-enhanced magnetic resonance imaging.
    Li Z; Sun J; Chen L; Huang N; Hu P; Hu X; Han G; Zhou Y; Bai W; Niu T; Yang X
    J Magn Reson Imaging; 2016 Jul; 44(1):98-104. PubMed ID: 26707910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reproducibility of the aortic input function (AIF) derived from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of the kidneys in a volunteer study.
    Mendichovszky IA; Cutajar M; Gordon I
    Eur J Radiol; 2009 Sep; 71(3):576-81. PubMed ID: 19004588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlations of 3T DCE-MRI quantitative parameters with microvessel density in a human-colorectal-cancer xenograft mouse model.
    Ahn SJ; An CS; Koom WS; Song HT; Suh JS
    Korean J Radiol; 2011; 12(6):722-30. PubMed ID: 22043155
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of quantitative parameters in cervix cancer measured by dynamic contrast-enhanced MRI and CT.
    Yang C; Stadler WM; Karczmar GS; Milosevic M; Yeung I; Haider MA
    Magn Reson Med; 2010 Jun; 63(6):1601-9. PubMed ID: 20512864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamic Contrast-Enhanced MRI Using a Macromolecular MR Contrast Agent (P792): Evaluation of Antivascular Drug Effect in a Rabbit VX2 Liver Tumor Model.
    Park HS; Han JK; Lee JM; Kim YI; Woo S; Yoon JH; Choi JY; Choi BI
    Korean J Radiol; 2015; 16(5):1029-37. PubMed ID: 26357497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of Indicator Dilution Principle to Evaluate Accuracy of Arterial Input Function Measured With Low-Dose Ultrafast Prostate Dynamic Contrast-Enhanced MRI.
    Wang S; Fan X; Zhang Y; Medved M; He D; Yousuf A; Jamison E; Oto A; Karczmar GS
    Tomography; 2019 Jun; 5(2):260-265. PubMed ID: 31245547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Free-breathing quantitative dynamic contrast-enhanced magnetic resonance imaging in a rat liver tumor model using dynamic radial T(1) mapping.
    Braren R; Curcic J; Remmele S; Altomonte J; Ebert O; Rummeny EJ; Steingoetter A
    Invest Radiol; 2011 Oct; 46(10):624-31. PubMed ID: 21577121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relative sensitivities of DCE-MRI pharmacokinetic parameters to arterial input function (AIF) scaling.
    Li X; Cai Y; Moloney B; Chen Y; Huang W; Woods M; Coakley FV; Rooney WD; Garzotto MG; Springer CS
    J Magn Reson; 2016 Aug; 269():104-112. PubMed ID: 27288764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DCE-MRI using small-molecular and albumin-binding contrast agents in experimental carcinomas with different stromal content.
    Farace P; Merigo F; Fiorini S; Nicolato E; Tambalo S; Daducci A; Degrassi A; Sbarbati A; Rubello D; Marzola P
    Eur J Radiol; 2011 Apr; 78(1):52-9. PubMed ID: 19443159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Parametric maps of spatial two-tissue compartment model for prostate dynamic contrast enhanced MRI - comparison with the standard Tofts model in the diagnosis of prostate cancer.
    Zhou X; Fan X; Chatterjee A; Yousuf A; Antic T; Oto A; Karczmar GS
    Res Sq; 2023 Feb; ():. PubMed ID: 36798227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Repeatability and correlations of dynamic contrast enhanced and T2* MRI in patients with advanced pancreatic ductal adenocarcinoma.
    Klaassen R; Gurney-Champion OJ; Wilmink JW; Besselink MG; Engelbrecht MRW; Stoker J; Nederveen AJ; van Laarhoven HWM
    Magn Reson Imaging; 2018 Jul; 50():1-9. PubMed ID: 29476781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimized Fast Dynamic Contrast-Enhanced Magnetic Resonance Imaging of the Prostate: Effect of Sampling Duration on Pharmacokinetic Parameters.
    Othman AE; Falkner F; Martirosian P; Schraml C; Schwentner C; Nickel D; Nikolaou K; Notohamiprodjo M
    Invest Radiol; 2016 Feb; 51(2):106-12. PubMed ID: 26447494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of artery input function on dynamic contrast-enhanced MRI for determining grades of gliomas.
    Jia L; Wu X; Wan Q; Wan L; Jia W; Zhang N
    Br J Radiol; 2021 Mar; 94(1119):20200699. PubMed ID: 33332981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluating the Relationship Between Dynamic Contrast-Enhanced MRI (DCE-MRI) Parameters and Pathological Characteristics in Breast Cancer.
    Kang SR; Kim HW; Kim HS
    J Magn Reson Imaging; 2020 Nov; 52(5):1360-1373. PubMed ID: 32524658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Segmentation of dynamic contrast enhanced magnetic resonance imaging data.
    Nielsen T; Mouridsen K; Maxwell RJ; Stødkilde-Jørgensen H; Østergaard L; Horsman MR
    Acta Oncol; 2008; 47(7):1265-70. PubMed ID: 18661437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dynamic contrast-enhanced magnetic resonance imaging of tumors: preclinical validation of parametric images.
    Egeland TA; Simonsen TG; Gaustad JV; Gulliksrud K; Ellingsen C; Rofstad EK
    Radiat Res; 2009 Sep; 172(3):339-47. PubMed ID: 19708783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dynamic contrast-enhanced MRI parametric mapping using high spatiotemporal resolution Golden-angle RAdial Sparse Parallel MRI and iterative joint estimation of the arterial input function and pharmacokinetic parameters.
    Mazaheri Y; Kim N; Lakhman Y; Jafari R; Vargas A; Otazo R
    NMR Biomed; 2022 Jul; 35(7):e4718. PubMed ID: 35226774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamic fractal signature dissimilarity analysis for therapeutic response assessment using dynamic contrast-enhanced MRI.
    Wang C; Subashi E; Yin FF; Chang Z
    Med Phys; 2016 Mar; 43(3):1335-47. PubMed ID: 26936718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A compact solution for estimation of physiological parameters from ultrafast prostate dynamic contrast enhanced MRI.
    He D; Fan X; Chatterjee A; Wang S; Medved M; Pineda FD; Yousuf A; Antic T; Oto A; Karczmar GS
    Phys Med Biol; 2019 Aug; 64(15):155012. PubMed ID: 31220816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.